SPE.L

Sopheon Plc
Sopheon PLC - Issue of Equity
8th January 2024, 12:22
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9775Y
Sopheon PLC
08 January 2024
 


 

SOPHEON PLC

("Sopheon" or the "Company")

 

Issue of Equity

 

Sopheon, the InnovationOps software company, announces that following the exercise of options by a former employee it has allotted 13,726 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares").

 

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 12 January 2024.

 

The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,706,805. The Company does not hold any shares in treasury. Accordingly, the figure of 10,706,805 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), the Company confirms, pursuant to the exercise of options that there are currently 10,706,805 new Ordinary Shares of 20 pence each in issue in the Company and the International Securities Identification Number for Sopheon's Ordinary Shares is GB00BSZM136.

 

 

For further information contact:

Andy Michuda (Executive Chairman)
Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Abigail Kelly / George Dollemore (Corporate Finance) Sunila de Silva (ECM)

Cavendish Capital Markets Ltd

+ 44 (0) 20 7220 0500

 

About Sopheon. Sopheon (LSE: SPE) empowers organizations to change the world while achieving exceptional long-term revenue growth and profitability. By operationalizing the entire innovation life cycle, Accolade® and Acclaim™ software and expertise enable innovation, product and project professionals to accomplish the full range of InnovationOps tasks to drive innovation at scale. Sopheon's industry leadership was highlighted in the comprehensive MarketsandMarkets™ report on the Innovation Management market, in which Sopheon was listed in the "Stars" category, the highest recognition. Sopheon's solutions have been implemented by hundreds of blue-chip customers with over 125,000 users in 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange. For more information, please visit www.sopheon.com.  

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBDGDBBDGDGSI]]>
TwitterFacebookLinkedIn